# Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

> **NCT03882528** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 12 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** Plasmodium falciparum malaria parasite

## Key facts

- **NCT ID:** NCT03882528
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-04
- **Primary completion:** 2019-04-25
- **Final completion:** 2019-05-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882528, "Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03882528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*